Tango Therapeutics, Inc. (TNGX) earnings
Quarterly results of Tango Therapeutics, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Tango Therapeutics, Inc. is expected to report around January 7, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Tango Therapeutics, Inc. reported revenue of $0 and a net loss of $68.4M.
Diluted earnings per share were -$0.39.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $0 | - | -$68.4M | -$0.39 |
| Q2 FY2026 | $0 | - | -$55.3M | -$0.37 |
| Q1 FY2026 | $0 | - | -$45.5M | -$0.32 |
| Q4 FY2025 | $0 | - | -$38.7M | - |
| Q3 FY2025 | $53.8M | - | $15.9M | $0.13 |
| Q2 FY2025 | $3.2M | - | -$38.9M | -$0.35 |
| Q1 FY2025 | $5.4M | - | -$39.9M | -$0.36 |
| Q4 FY2024 | $4.1M | - | -$37.7M | - |
Results filings
- Quarterly results 8-K
- Quarterly report 10-Q
- Quarterly results 8-K
- Quarterly report 10-Q
When is Tango Therapeutics, Inc.'s next earnings date?
Tango Therapeutics, Inc. is expected to report around January 7, 2027. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.
What were Tango Therapeutics, Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Tango Therapeutics, Inc. reported revenue of $0 and a net loss of $68.4M. The figures come from its filing with the SEC.
Get an email when TNGX reports
Follow TNGX and we email you its next results the day they are filed, with the numbers explained.